Table 3.
Secondary outcome variables: morbidity and mortality.
| Variables | PAC (n = 70) | Control (n = 70) | P value |
|---|---|---|---|
| Days on ventilator | 7 (5–11) | 10 (6–18) | 0.01 |
| PO2/FiO2 ratio, worst (mmHg) | 196 ± 81 | 158 ± 64 | 0.003 |
| CVVH, n | 28 | 35 | 0.24 |
| CVVH, days | 0 (−5) | 0 (0–8) | 0.08 |
| RIFLE score, highest | 2 (0–3) | 3 (1–3) | 0.02 |
| LOS ICU (days) | 9 (6–13) | 14 (7–28) | 0.001 |
| LOS hospital | 24 (14–40) | 30 (17–51) | 0.16 |
| Cumulative SOFA score day 1–5 | 39 ± 15 | 40 ± 16 | 0.67 |
| Cumulative SOFA score day 1–5 survivors | 39 ± 12 | 38 ± 16 | 0.63 |
| Mortality ICU (n, %) | 15 (21) | 21 (30) | 0.33 |
| Mortality hospital (%) | 17 (24) | 27 (39) | 0.10 |
PAC: pulmonary artery catheter, FiO2: inspiratory oxygen fraction, CVVH: continous veno venous hemofiltration, RIFLE: risk injury failure loss and endstage, LOS: length of stay, SOFA: sequential organ failure assessment. Data are presented as mean ± SD, median (IQR) or as numbers (%).